Tivicay 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GR1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,067
Award facts
- Contract value 100% obligated
- $19,066.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $19,066.80 by the Defense Logistics Agency on December 18, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). The contract, which is neither set-aside nor subject to small business restrictions, represents a firm fixed-price delivery order with an ultimate completion date of December 19, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare systems globally.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp leverages its comprehensive product portfolio and established relationship with the Defense Logistics Agency to fulfill specialized pharmaceutical needs across the Military Health System. Tivicay, an antiretroviral medication for HIV treatment, represents one of the specialized therapeutic pharmaceuticals within the company's extensive federal contracting history. The firm fixed-price structure and rapid completion timeline reflect the urgent medical supply requirements typical of military healthcare procurement operations under the DLA's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26F9GR1?
SPE2DR26F9GR1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9GR1 worth?
The government has obligated $19,067 on SPE2DR26F9GR1.
Is contract SPE2DR26F9GR1 an order under another contract?
Yes. SPE2DR26F9GR1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GR1 competed?
The extent of competition for SPE2DR26F9GR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award